Product Catalog

27-0526

Cobalt › (1S,2S)-(+)-1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)cobalt(II)

CAS Number:	188264-84-8
MDL Number:	MFCD01631278
Molecular Formula:	C36H52CoN2O2
Molecular Weight:	603.76
Chemical Formula:	C36H52CoN2O2
Color and Form:	red-brown pwdr.
Note:	Sold in collaboration with Shasun.

Physical Characteristics: melting point 409-412°C

Please log in or choose your country below to view prices.

Buy 5 - 9 of an item and get a 5% discount.
Buy 10 or more of an item and get a 10% discount.

SECTION 1: Product Identification
Chemical Name:	(1S,2S)-(+)-1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)cobalt (II)
Product Number:	27-0526
CAS Registry Number:	188264-84-8
Formula:	C36H52CoN2O2
EINECS Number:	none
Chemical Family:	organometallic complexes
Synonym:	none

SECTION 2: Composition and Information on Ingredients
Ingredient	CAS Number	Percent	ACGIH (TWA)	OSHA (PEL)
Title Compound	188264-84-8	100	0.02mg/m3 (as Co)	no data

SECTION 3: Hazards Identification
Emergency Overview:	Causes irritation of eyes, skin, and respiratory tract. May cause lung disease, polycythemia, congestive failure, and enlargement of the thyroid. Limited evidence of a carcinogenic effect.
Primary Routes of Exposure:	Skin and eyes, ingestion and dust inhalation.
Eye Contact:	Causes irritation, redness, and pain.
Skin Contact:	May cause dermatitis. Causes irritation to skin. Symptoms include redness, itching, and pain.
Inhalation:	Causes irritation to the respiratory tract. Symptoms may include coughing, shortness of breath, nausea, respiratory hypersensitivity, asthma.
Ingestion:	Causes abdominal pain, nausea, vomiting, flushing of the face and ears, mild hypo tension, rash, and ringing in the ears.
Acute Health Effects:	Irritating to skin, eyes and respiratory tract. Causes abdominal pain, nausea, vomiting, coughing, and shortness of breath.
Chronic Health Effects:	Repeated oral administration of cobalt salts may reduce thyroid activity, cause blood disease, and damage kidney, heart and lungs. Prolonged or repeated skin exposure may cause dermatitis. Limited evidence of a carcinogenic effect.
NTP:	No
IARC:	No
OSHA:	No

SECTION 4: First Aid Measures
Eye Exposure:	Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention.
Skin Exposure:	Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists.
Inhalation:	Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Ingestion:	Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:	not applicable
Autoignition Temperature:	none
Explosion Limits:	none
Extinguishing Medium:	carbon dioxide, foam or dry powder
Special Fire Fighting Procedures:	If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure self- contained breathing apparatus and full protective clothing.
Hazardous Combustion and Decomposion Products:	If involved in a fire this material may emit toxic organic fumes.
Unusual Fire or Explosion Hazards:	No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Spill and Leak Procedures:	Small spills can be mixed with vermiculite, sodium carbonate or other suitable non combustible adsorbent and swept up.

SECTION 7: Handling and Storage
Handling and Storage:	Store in a tightly sealed container away from heat and direct sunlight.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:	Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:	Wear protective clothing and gloves.
Ventilation:	Material may form a fine dust. If possible, handle the material in an efficient fume hood.
Respirator:	If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134.
Additional Protection:	No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:	red-brown pwdr.
Molecular Weight:	603.76
Melting Point:	409-412°C
Boiling Point:	no data
Vapor Pressure:	not applicable
Specific Gravity:	no data
Odor:	none
Solubility in Water:	insoluble

SECTION 10: Stability and Reactivity
Stability:	air and moisture stable
Hazardous Polymerization:	no hazardous polymerization
Conditions to Avoid:	none
Incompatibility:	oxidizing agents
Decomposition Products:	carbon dioxide, carbon monoxide, nitrogen oxides, organic fumes, and cobalt oxide.

SECTION 11: Toxicological Information
RTECS Data:	No information available in the RTECS files.
Carcinogenic Effects:	Possible carcinogen
Mutagenic Effects:	No data
Tetratogenic Effects:	No data

SECTION 12: Ecological Information
Ecological Information:	No information available

SECTION 13: Disposal Considerations
Disposal:	Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):	Non-hazardous
Hazard Class (CFR):	NA
Additional Hazard Class (CFR):	NA
Packaging Group (CFR):	NA
UN ID Number (CFR):	NA
Shipping Name (IATA):	Non-hazardous
Hazard Class (IATA):	NA
Additional Hazard Class (IATA):	NA
Packaging Group (IATA):	NA
UN ID Number (IATA):	NA

SECTION 15: Regulatory Information
TSCA:	Not listed in the TSCA inventory.
SARA (Title 313):	Title compound: See category N096 for reporting.
Second Ingredient:	None
Third Ingredient:	None

SECTION 16: Other Information
Disclaimer:	The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information.
Preparation Date:	3/11/2002
Revision Date:	6/22/2004